SSI
REGN icon

Scott & Selber Inc’s Regeneron Pharmaceuticals REGN Stock Holding History

Scott & Selber Inc’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-2,603
Closed -$1.46M – 109
2020
Q3 		$1.46M Buy
2,603
+71
+3% +$43K 0.65% 68
2020
Q2 		$1.58M Sell
2,532
-33
-1% -$18.7K 0.78% 57
2020
Q1 		$1.25M Buy
+2,565
New +$1.06M 0.78% 57
2016
Q1 		– Sell
-5,899
Closed -$3.2M – 74
2015
Q4 		$3.2M Buy
5,899
+44
+0.8% +$23.8K 2.08% 15
2015
Q3 		$2.72M Buy
5,855
+12
+0.2% +$6.44K 2.01% 18
2015
Q2 		$2.98M Buy
5,843
+60
+1% +$29.3K 2.05% 20
2015
Q1 		$2.61M Sell
5,783
-354
-6% -$150K 1.76% 25
2014
Q4 		$2.52M Buy
6,137
+19
+0.3% +$7.47K 1.69% 28
2014
Q3 		$2.21M Buy
+6,118
New +$2.05M 1.54% 40
2014
Q2 		– Sell
-8,029
Closed -$2.41M – 75
2014
Q1 		$2.41M Sell
8,029
-59
-0.7% -$18.2K 1.69% 30
2013
Q4 		$2.23M Buy
8,088
+121
+2% +$34.8K 1.63% 40
2013
Q3 		$2.49M Hold
7,967
– – 2.01% 16
2013
Q2 		$1.79M Buy
+7,967
New +$1.86M 1.57% 43

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $11.6B AUM 8.03% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Scott & Selber Inc's REGN Position: Q4 2020 in Review

Scott & Selber Inc sold out of Regeneron Pharmaceuticals (REGN) in Q4 2020, closing a stake of 2,603 shares — an estimated $1.46M sold.

Scott & Selber Inc first reported a position in REGN in Q2 2013 and held it in 13 quarters. The position peaked at $3.2M in Q4 2015. 904 funds tracked by Wall St. Rank hold REGN as of Q4 2020.

  • Scott & Selber Inc reported no remaining Regeneron Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Scott & Selber Inc sold 2,603 Regeneron Pharmaceuticals shares in Q4 2020, an estimated $1.46M.
  • Scott & Selber Inc first reported a position in Regeneron Pharmaceuticals in Q2 2013 and held it in 13 quarters.
  • Scott & Selber Inc's Regeneron Pharmaceuticals position peaked at $3.2M in Q4 2015.
  • 904 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2020.

Based on Scott & Selber Inc's 13F filing for Q4 2020, filed 4 Feb 2021.